Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cellectis S.A. ADR (CLLS)

Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cellectis S.A. ADR 8 RUE DE LA CROIX JARRY PARIS I0 75013 FRA

www.cellectis.com Employees: 221 P: 33-1-81-69-16-00 F: +33 181691606

Description:

Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.

Key Statistics

Overview:

Market Capitalization, $K 91,158
Enterprise Value, $K 8,868
Shares Outstanding, K 55,584
Annual Sales, $ 9,190 K
Annual Net Income, $ -101,060 K
Last Quarter Sales, $ 18,050 K
Last Quarter Net Income, $ -23,060 K
EBIT, $ -78,420 K
EBITDA, $ -59,900 K
60-Month Beta 3.09
% of Insider Shareholders 16.41%
% of Institutional Shareholders 63.90%
Float, K 46,463
% Float 83.59%
Short Volume Ratio 0.16

Growth:

1-Year Return -53.80%
3-Year Return -80.82%
5-Year Return -90.83%
5-Year Revenue Growth -57.12%
5-Year Earnings Growth -6.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 11/04/24
Next Earnings Date N/A
Earnings Per Share ttm -1.30
EPS Growth vs. Prev Qtr 17.86%
EPS Growth vs. Prev Year 25.81%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CLLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -74.55%
Return-on-Assets % -22.65%
Profit Margin % -1,099.67%
Debt/Equity 0.52
Price/Sales 9.61
Price/Cash Flow N/A
Price/Book 0.68
Book Value/Share 2.33
Interest Coverage -1.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar